The Immunologist
Performance since launch
Backtest volatility
About this strategy
Scores each morning's vaccine headlines across eleven liquid vaccine makers and rides confirmed clinical and regulatory catalysts for about a week, benched in the biotech sector between events.
How it works
- Agent triggers
Runs daily at 09:20 ET, reading the most recent vaccine headlines. Morning news analysis, scoring eleven liquid vaccine makers.
- Computes its signals
It evaluates news for clinical and regulatory catalysts, awarding scores based on headline relevance to decide which stocks to trade.
- Sets the target portfolio
The target portfolio can contain up to 5 names, weighted by their scores and capped at 30% each. Cash is temporarily held in a biotech ETF when no trades are active.
- Executes orders
Your account trades toward the target, sells before buys, inside the platform's risk rails: stop-loss and daily loss limits you control.
Ask this agent
. Preview chat needs an account.
Answers describe the strategy’s rules, not investment advice.
Backtests
* Backtest figures are simulated based on historical market data. Past performance is not indicative of future results.